A Possible New Parkinson’s Treatment
Though the research is still in it’s early stages, there is optimism behind a diabetes drug, exenatide, known commercially as Byetta, being used to treat Parkinson’s disease. The drug is actually a synthetic version of Gila monster saliva and performed well as a treatment in a small, proof-of-concept study on Parkinson’s patients.
As Paulina Anderson reports for Medscape, the results are enough to get funding for a larger study, which could really move things forward and get much closer to using exenatide in Parkinson’s treatments. Considering patients in the small, initial study showed marked improvement, action to get this treatment into use is certainly needed.